Monday Morning Session Orange Oral Presentations
Monday, April 28, 2014: 9:15 AM-9:45 AM
9:15 AM
The Role of Injectables in Aesthetic Surgery: Financial Implications
William Schleicher, M.D., Bryson G. Richards, M.D., George Collis, M.D., Deepa Cherla, M.D., Raymond Isakov, M.D. and James E. Zins, M.D., F.A.C.S., Cleveland Clinic, Cleveland, OH
9:23 AM
A Randomized Controlled Trial of the EmbraceŽ Device to Reduce Incisional Scar Formation
Michael Longaker, MD, FACS1, Rod J. Rohrich, MD, FACS2, Lauren Greenberg, MD3, Heather Furnas, MD4, Robert Wald, MD5, Vivek Bansal, MD6, Hisham Seify, MD7, Anthony Tran, MD8, Jane Weston, MD9, Joshua Korman, MD10, Rodney Chan, MD11, David Kaufman, MD12, Vipul Dev, MD13, Joseph Mele, MD14, Michael Januszyk, MD1, Christy Cowley15, Peggy McLaughlin15, Bill Beasley15 and Geoffrey C. Gurtner, MD1, (1)Stanford University, Stanford, CA, (2)UT Southwestern Medical Center, Dallas, TX, (3)Lauren Greenberg MD, Palo Alto, CA, (4)Plastic Surgery Associates, Santa Rosa, CA, (5)The Aesthetic Institute, Fullerton, CA, (6)Elite MD, Danville, CA, (7)Newport Plastic & Reconstructive Surgery Associates, Newport Beach, CA, (8)8Arlington Plastic Surgery, Arlington, TX, (9)9Atherton Plastic Surgery, Atherton, CA, (10)Korman Plastic Surgery, Mountain View, CA, (11)STARS Plastic Surgery, San Antonio, TX, (12)Kaufman & Clark Plastic Surgery, Folsom, CA, (13)VIP DEV, MD, Bakersfield, CA, (14)JOSEPH MELE, MD, Walnut Creek, (15)Neodyne Biosciences, Menlo Park, CA
